Meenakshi et al., 2001 - Google Patents
Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluationMeenakshi et al., 2001
View PDF- Document ID
- 13591161624142936281
- Author
- Meenakshi A
- Kumar R
- Kumar N
- Publication year
- Publication venue
- Human antibodies
External Links
Snippet
Abstract The C-erbB-2 proto-oncogene encodes the production of a cell surface receptor protein, with tyrosine kinase activity. Over expression of this gene either due to gene amplification and/or increased transcription has been observed and has been correlated …
- 108010069858 CIBCgp185 monoclonal antibody 0 title abstract description 22
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Miotti et al. | Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity | |
| AU645760B2 (en) | C-erbb-2 external domain: GP75 | |
| US7247476B2 (en) | Individualized anti-cancer antibodies | |
| Goddard et al. | Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. | |
| US20040001789A1 (en) | Cytotoxicity mediation of cells evidencing surface expression of gp96 or precursors thereof | |
| DE3856004T2 (en) | USE OF MONOCLONAL RECEPTORS AGAINST ONCOPROTEINS FOR MONITORING CANCER THERAPY | |
| Maleki et al. | Production and characterization of murine monoclonal antibody against synthetic peptide of CD34 | |
| DIGIESI et al. | Production and characterization of murine mAbs to the extracellular domain of human neu oncogene product GP185HER2 | |
| CENTIS et al. | p185 HER2/neu epitope mapping with murine monoclonal antibodies | |
| JP2010529950A (en) | All (PAN) cancer markers containing sugar | |
| Meenakshi et al. | Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluation | |
| EP0154550A2 (en) | Monoclonal antibodies capable of binding to pancreatic carcinoma of ductal origin | |
| Tominaga et al. | Detection of p73 antibodies in patients with various types of cancer: immunological characterization | |
| JPH03502759A (en) | Monoclonal antibody against activated Ras protein with amino acid mutation at position 13 of the protein | |
| AU2001226985B2 (en) | Individualized anti-cancer antibodies | |
| JPS61180799A (en) | Monoclonal antibody | |
| AU618209B2 (en) | Antigen recognized by mca 16-88 | |
| DE68928106T2 (en) | DETECTION, QUANTIFICATION AND CLASSIFICATION OF RAS PROTEINS IN BODY LIQUIDS AND TISSUES | |
| Endo et al. | Two murine monoclonal antibodies against human lung cancer-associated antigens | |
| US5032521A (en) | Monoclonal antibody specific for a mammary tumor cell surface antigen | |
| Buto et al. | Production and characterization of monoclonal antibodies directed against the laminin receptor precursor | |
| WANG et al. | Monoclonal antibodies against a 65-kDa tumor-associated phosphoprotein: Development and use in cancer detection | |
| JP3076926B2 (en) | Kaposi's sarcoma growth inhibitor | |
| JPH03240498A (en) | Antibodies and immunoassay methods using them | |
| Glasky et al. | Adenocarcinoma-reactive human monoclonal antibody MS2B6 defines an antigen in simple glandular epithelium |